Randomized controlled trial of transarterial Lipiodol chemoembolization for unresectable hepatocellular carcinoma

Hepatology

Volumn 35, Issue 5, 2002, Pages 1164-1171

  Lo, Chung Mau ^a   Ngan, Henry ^a   Tso, Wai Kuen ^a   Liu, Chi Leung ^a   Lam, Chi Ming ^a   Poon, Ronnie Tung Ping ^a   Fan, Sheung Tat ^a   Wong, John ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CISPLATIN; GELATIN SPONGE; GENTAMICIN; IODINATED POPPYSEED OIL; MANNITOL; SPONGOSTAN; SUCRALFATE; TROPISETRON;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; ASIAN; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; INOPERABLE CANCER; LIVER CELL CARCINOMA; LIVER FAILURE; MALE; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS;

EID: 0036237822     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.33156     Document Type: Article

References (31)

1. Global epidemiology of hepatocellular carcinoma
2. Treatment of hepatocellular carcinoma
3. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation
4. A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge
5. Regional intra-arterial infusion of cisplatin in primary hepatocellular carcinoma. A phase II study
6. A 5-year experience of lipiodolisation: Selective regional chemotherapy for 200 patients with hepatocellular carcinoma
7. Non-operative arterial embolization in primary liver tumors
8. Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma - A randomized controlled trial
9. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution
10. Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil
11. Transcatheter oily chemoembolization in the management of advanced hepatocellular carcinoma in cirrhosis: Results of a Western comparative study in 60 patients
12. Primary treatment of hepatocellular carcinoma by arterial chemoembolization
13. Treatment of inoperable hepatocellular carcinoma by transcatheter arterial chemoembolization using an emulsion of cisplatin in iodized oil and gelfoam
14. Efficacy of transarterial targeted treatments on survival of patients with hepatocellular carcinoma
15. A comparison of chemoembolization with conventional chemotherapy and symptomatic treatment in cirrhotic patients with hepatocellular carcinoma
16. Treatment of hepatocellular carcinoma using doxorubicin/ethiodized oil/gelatin powder chemoembolization
17. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma
18. Randomised trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma
19. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma
20. Ethnic differences in the behavior of hepatocellular carcinoma
21. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan
22. Primary liver cancer. An Eastern Cooperative Oncology Group trial
23. Pharmacokinetic study on the hepatic uptake of indocyanine green in cirrhotic patients
24. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: Study of 850 patients
25. Nonparametric estimation from incomplete observations
26. Regression models and life-tables
27. Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials
28. Natural history of inoperable hepatocellular carcinoma: Estrogen receptors' status in the tumor is the strongest prognostic factor for survival
29. Hepatocellular carcinoma. Prognostic factors and survival analysis in 135 Italian patients
30. Clinical features and prognosis of hepatocellular carcinoma with reference to serum α-fetoprotein levels. Analysis of 606 patients
31. Prognostic factors of hepatocellular carcinoma in the west: A multivariate analysis in 206 patients